Agile Therapeutics, Inc. (AGRX)

NASDAQ: AGRX · IEX Real-Time Price · USD
0.683
+0.011 (1.70%)
At close: Jul 6, 2022 4:00 PM
0.724
+0.042 (6.081%)
Pre-market: Jul 7, 2022 5:51 AM EDT

Income Statement (Quarterly)

Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Quarter Ended 2022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-31
Revenue
1.761.511.291.190.120.750000000000000000000000000000000
Revenue Growth (YoY)
1418.10%102.14%-----------------------------------
Cost of Revenue
1.535.72.711.151.160.280000000000000000000000000000000
Gross Profit
0.23-4.19-1.420.04-1.050.470000000000000000000000000000000
Selling, General & Admin
14.5516.4912.7615.8313.0514.210.996.384.453.272.141.771.831.571.772.323.093.253.533.22.412.32.182.262.052.251.81.811.61.551.451.11.050.670.920.821.16
Research & Development
1.261.681.590.862.123.013.663.663.162.842.361.782.881.861.552.413.962.733.183.84.725.514.915.584.936.917.166.175.384.984.62.391.391.262.42.433.07
Other Operating Expenses
00000000000000.30.30.42000000000000000000000
Operating Expenses
15.8118.1714.3516.6915.1817.2114.6610.047.626.114.53.554.713.733.625.157.055.996.777.137.817.097.846.989.178.977.986.986.526.053.492.451.933.323.254.23
Operating Income
-15.57-22.36-15.77-16.65-16.22-16.74-14.66-10.04-7.62-6.11-4.5-3.55-4.71-3.73-3.62-5.15-7.05-5.99-6.7-7-7.13-7.81-7.09-7.84-6.98-9.17-8.97-7.98-6.98-6.52-6.05-3.49-2.45-1.93-3.32-3.25-4.23
Interest Expense / Income
0.87110.990.920.90.910.90.400000.160.270.320.370.410.460.50.550.570.780.550.550.550.550.550.430.390.390.40.380.380.380.380.38
Other Expense / Income
-0-0-0-0.01-0.02-0.03-0.04-0.12-0.13-0.08-0.07-0.06-0.04-0.08-0.09-0.12-0.1-0.16-0.06-0.05-0.16-0.1-0.070.03-0.210.15-0.11-0.041.14-0.07-0.09-0.18-0.010.11-0.01-0.01-0
Pretax Income
-16.44-23.36-16.77-17.64-17.13-17.62-15.52-10.83-7.88-6.02-4.43-3.48-4.67-3.81-3.79-5.34-7.31-6.24-7.1-7.45-7.52-8.28-7.8-8.42-7.32-9.87-9.41-8.49-8.54-6.85-6.35-3.72-2.81-2.41-3.69-3.62-4.61
Income Tax
-4.68000000000000000-0.480000-3.08000-5.97000-000-3.650000
Net Income
-11.77-23.36-16.77-17.64-17.13-17.62-15.52-10.83-7.88-6.02-4.43-3.48-4.67-3.81-3.79-5.34-6.83-6.24-7.1-7.45-7.52-5.2-7.8-8.42-7.32-3.9-9.41-8.49-8.54-6.84-6.35-3.720.84-2.41-3.69-3.62-4.61
Net Income Common
-11.77-23.36-16.77-17.64-17.13-17.62-15.52-10.83-7.88-6.02-4.43-3.48-4.67-3.81-3.79-5.34-6.83-6.24-7.1-7.45-7.52-5.2-7.8-8.42-7.32-3.9-9.41-8.49-8.54-6.84-6.35-3.720.84-2.41-3.69-3.62-4.61
Shares Outstanding (Basic)
3222222221111111111111111111100000000
Shares Outstanding (Diluted)
3222222221111111111111111111100000000
Shares Change
42.20%10.98%7.33%1.69%14.32%76.95%62.94%99.24%105.46%43.79%55.94%27.71%9.00%0.46%7.64%19.01%18.98%18.98%11.07%0.20%7.24%28.98%29.10%29.46%26.05%95.70%19.79%177.53%2488.63%21530.52%36016.86%15440.17%1848.25%----
EPS (Basic)
-3.78-8.00-7.20-8.00-8.00-8.00-7.20-4.80-4.00-4.00-3.20-3.20-5.20-4.40-4.40-6.40-8.00-6.80-8.80-10.40-10.40-7.20-10.80-11.60-10.80-6.80-16.80-15.20-16.00-15.20-13.60-18.404.00-1.00-2.00-2.00-4.00
EPS (Diluted)
-3.78-8.00-7.20-8.00-8.00-8.00-7.20-4.80-4.00-4.00-3.20-3.20-5.20-4.40-4.40-6.40-8.00-6.80-8.80-10.40-10.40-7.20-10.80-11.60-10.80-6.80-16.80-15.20-16.00-15.20-13.60-18.400.40-1.00-2.00-2.00-4.00
Free Cash Flow Per Share
-4.78-6.87-7.96-6.95-6.73-7.96-7.05-3.13-4.20-2.70-3.81-2.17-5.32-3.65-4.48-4.94-7.00-7.42-8.96-8.83-8.36-4.07-10.28-8.73-10.05-9.09-12.98-13.75-10.97-19.54-16.81-10.75350.12-1.00-3.00-9.00882.40
Gross Margin
13.29%-276.55%-110.64%3.38%-900.86%62.35%-------------------------------
Operating Margin
-884.33%-1476.75%-1225.64%-1405.15%-13984.48%-2235.11%-------------------------------
Profit Margin
-668.31%-1542.73%-1303.19%-1488.35%-14765.52%-2352.47%-------------------------------
Free Cash Flow Margin
-844.80%-1101.25%-1448.72%-1300.76%-12706.03%-2322.96%-------------------------------
Effective Tax Rate
28.43%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%6.53%0.00%0.00%0.00%0.00%37.16%0.00%0.00%0.00%60.50%0.00%0.00%0.00%0.01%0.00%0.00%129.83%0.00%0.00%0.00%0.00%
EBITDA
-14.98-21.78-15.22-16.09-15.66-16.59-14.56-9.88-7.44-5.98-4.39-3.45-4.63-3.64-3.52-5.02-6.94-5.82-6.64-6.94-6.97-7.7-7.02-7.87-6.77-9.32-8.86-7.93-8.11-6.45-5.96-3.31-2.43-2.03-3.31-3.24-4.22
EBITDA Margin
-850.88%-1438.70%-1182.67%-1358.14%-13500.00%-2214.55%-------------------------------
Depreciation & Amortization
0.590.580.550.550.550.130.060.050.040.040.040.040.040.010.010.010.010.010.010.010.010.010.010.010000.010.0100000000
EBIT
-15.57-22.36-15.77-16.64-16.21-16.72-14.62-9.92-7.49-6.02-4.43-3.48-4.67-3.65-3.52-5.02-6.94-5.83-6.64-6.94-6.97-7.71-7.02-7.87-6.77-9.32-8.86-7.94-8.11-6.45-5.96-3.31-2.43-2.03-3.31-3.24-4.23
EBIT Margin
-884.27%-1476.68%-1225.56%-1404.56%-13970.69%-2231.78%-------------------------------
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).